Anastrozole Tablet
Product Images NDC 68071-5203

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 68071-5203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5203 3)

FDA Label Image

Figure 1 (Anastrozole Fig1)

FDA Label Image

Figure 2 (Anastrozole Fig2)

FDA Label Image

Figure 3 (Anastrozole Fig3)

FDA Label Image

Figure 4 (Anastrozole Fig4)

FDA Label Image

Figure 5 (Anastrozole Fig5)

Figure 5 (Anastrozole Fig5)
This text seems to be a report related to a medical condition. The report might be documenting the progress of a treatment involving two drugs - Anastrozole and Tamoxifen. The report includes a table showing some values over a period of time but without any clear headings or context. The text seems to be missing some important details and lacks overall coherence.*
FDA Label Image

Figure 6 (Anastrozole Fig6)

FDA Label Image

Chemical Structure For Anastrozole (Anastrozole Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.